Minutes of the Management Board meeting: 17-18 December 2025

European Medicines Agency (EMA) stakeholder relations management framework

Human medicines European public assessment report (EPAR): Adenuric, febuxostat, Date of authorisation: 21/04/2008, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Fluad Tetra, influenza vaccine (surface antigen, inactivated, adjuvanted), Date of authorisation: 20/05/2020, Revision: 10, Status: Withdrawn

Standard operating procedure for annual review of VeDDRA list to be used in EudraVigilance Veterinary

Human medicines European public assessment report (EPAR): Kisunla, donanemab, Date of authorisation: 24/09/2025, Revision: 3, Status: Authorised

New product information wording – Extracts from PRAC recommendations on signals adopted at the 28-31 October 2024 PRAC

Human medicines European public assessment report (EPAR): Revolade, eltrombopag, Date of authorisation: 11/03/2010, Revision: 39, Status: Authorised

EMA/PE/0000226657